“…For the more than five donor heart group, this revealed independent factors associated with mortality to be pretransplant extracorporeal membrane oxygenation (ECMO), pretransplant dialysis, ischemic etiology for heat failure and O blood type donor hearts. 1 While these recipient and donor risk factors are largely nonmodifiable, there are developing molecular therapeutic strategies to increase the resilience of donor hearts to ischemic injury during preservation as well as introduction into a hostile recipient. Research is currently underway to inhibit inflammatory (e.g., inflammasome) and cell death pathways that occur during cold storage and in the setting of deceased cardiac death donation.…”